World Patient Safety Congress Europe 2026
As a recognized leader in safety and risk management for specialty therapies, UBC partners with biopharma sponsors to deliver sophisticated, tech-enabled pharmacovigilance and risk management solutions that are regulatory compliant, globally scalable, and purpose-built for complex programs. Our decades of experience across specialty therapeutic areas, including oncology, rare disease, cell therapy, and gene therapy, means we understand the unique safety challenges your program faces and how to address them with precision and confidence.
Stop by and meet with us at Booth #415!
- Pharmacovigilance: Global safety surveillance, signal detection, case processing, aggregate reporting, and health authority interactions designed to meet evolving EMA, FDA, and international regulatory expectations.
- Safety & Risk Management:REMS program design and implementation, EU risk minimization strategies, and integrated benefit/risk assessment tailored to your therapy and patient population.
- QPPV Support: Expert resources and infrastructure to support your Qualified Person for Pharmacovigilance obligations and ensure ongoing GVP compliance.
- Inspection Readiness: Proven strategies and operational frameworks to keep your pharmacovigilance system audit-ready and aligned with global regulatory standards.
Connect with UBC at the World Drug Safety Congress Europe 2026 to learn how our pharmacovigilance and risk management solutions can safeguard your program and support better patient outcomes.
Schedule a Meeting
Learn More About UBC
We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.
Other Events
ASH Annual Meeting 2026
Copay and Patient Services Congress 2026
ISPOR Europe 2026
Schedule a Meeting
Thank You for Connecting with UBC
.
What You Can Expect Next
.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.